What is Gyre Therapeutics, Inc.'s inventories?

Gyre Therapeutics, Inc. (GYRE) reported inventories of $11.35M in Q1 2026.

How has Gyre Therapeutics, Inc.'s inventories changed year-over-year?

Gyre Therapeutics, Inc.'s inventories increased by 44.1% year-over-year, from $7.88M to $11.35M.

What is the long-term trend for Gyre Therapeutics, Inc.'s inventories?

Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s inventories has grown at a 74.1% compound annual growth rate (CAGR), from $6.78M to $35.76M.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

Gyre Therapeutics, Inc. GYRE Inventories

Inventories at other companies

Eli LillyLLY

$14.49B+56.1%

Madrigal Pharmaceuticals, Inc.MDGL

$112.07M+103%

Rigel PharmaceuticalsRIGL

$11.65M+150%

Zevra Therapeutics, Inc.ZVRA

$0-100%

LQD

Liquidia CorporationLQDA

$28.51M+2,013%

BridgeBio PharmaBBIO

$32.98M+734%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryGross.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s inventories?: Gyre Therapeutics, Inc. (GYRE) reported inventories of $11.35M in Q1 2026.
How has Gyre Therapeutics, Inc.'s inventories changed year-over-year?: Gyre Therapeutics, Inc.'s inventories increased by 44.1% year-over-year, from $7.88M to $11.35M.
What is the long-term trend for Gyre Therapeutics, Inc.'s inventories?: Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s inventories has grown at a 74.1% compound annual growth rate (CAGR), from $6.78M to $35.76M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.